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Binding of two colchicine analogues, desacetamidocolchicine and 2-methoxy-5-(2’,3’,4’-trimethoxyphenyl) 
tropone to purified tubulin have been studied. Both analogues bind to tubulin with a significant increase 
in fluorescence polarization of the drugs in solutions containing tubulin. The Kd for tubulin-drug 
complexes were found to be 1.25 x 10m6 M and 1.08 x lOA M for desacetamidocolchicine and 
2-methoxy-5-(2’,3’,4’-trimethoxyphenyl) tropone, respectively. Scatchard analysis of the fluorescence 
titration curve of drug tubulin interaction also gives the values of stoichiometry and affinity constant. 
These were 0.8 and 1.6 x lo6 M-’ for desacetamidocolchicine, and 0.9 and 0.58 x lo6 M-’ for 
2-methoxy-5-(2’,3’,4’-trimethoxyphenyl) tropone. 
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1. INTRODUCTION 
Colchicine binds to native tubulin with stoichio- 
metry of 1 mol alkaloid per mol tubulin dimer. 
Several features of this colchicine binding reaction 
are unusual and the question arose whether or not 
they were a property of colchicine or of the binding 
site. The rates of association and dissociation of 
colchicine and tubulin are slow: the activation 
energy for the binding reaction is about 20 kcal/mol 
[l]. Although no direct proof exists, there are evi- 
dences which indicate that this slow rate of colchi- 
tine binding reflects a ligand-induced conforma- 
tional change in tubulin molecule [2-51. Recently, 
authors in [6] presented circular dichroic measure- 
ments indicating that colchicine itself undergoes a 
change in conformation upon binding to tubulin. 
We have recently shown that the slow association 
rate of colchicine is a phenomenon of the B-ring 
substituent of colchicine molecule [7,8]. Inspection 
of the structures of the B-ring analogues of colchi- 
tine (fig.1) reveals that, unlike colchicine and 
desacetamidocolchicine, the fluorophore (tropo- 
lone moiety) of 2-methoxy-5-(2’,3’,4’-trimethoxy- 
phenyl) tropone can assume an infinity of confor- 
mations due to free rotation around the single 
bond between A and C-rings. It seems likely that 
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Fig. 1, Structure of colchicine and some of its analogues. 
Published by Elsevier Science Publishers B. V. 
00145793/83/$3.00 0 1983 Federation of European Biochemical Societies 
CH30 
2- mothoxy -S-(2: 3: 4’- 
trimethoxyphcnyl)troponc 
55 
Volume 161, number 1 FEBS LETTERS September 1983 
the active conformation would be similar to that of 
cokhicine, since isocolchicine (fig.1) has no tubu- 
lin binding ability [9]. In fact, colchicine and iso- 
colchicine can be considered as semi-rigid analogues 
of bicyclic compound. The rigidity in colchicine 
and desacetamidocolchicine molecule is imparted 
by the B-ring which anchored the A and C-ring. 
Thus it was anticipated that the fluorescence polari- 
zation which depends on the size, molecular geo- 
metry and rigidity of a molecule might be different 
for desacetamidocolchicine and 2-methoxy-5- 
(2’,3’,4’-trimethoxyphenyl) tropone when they 
bind with tubulin. Here some important binding 
properties of these two drugs with tubulin have 
been reported. 
2. MATERIALS AND METHODS 
Tubulin was prepared from goat brain according 
to [lo]. The two cycles pellet was kept in - 70°C 
and tubulin was further purified by phosphocellu- 
lose chromatography [l 11. The purity of the tubu- 
lin was checked by SDS-gel electrophoresis [12]. 
The concentration of protein was determined as in 
[13] using bovine serum albumin as standard. 
Fluorescence was measured in a Perkin-Elmer 
MPF 44B fluorescent spectrophotometer. Tem- 
perature was controlled with LKB 2209 Multitemp 
water circulator. The excitation and emission wave- 
lengths were 350 nm and 430 nm, respectively. 
Polarization was done in the same spectrofluoro- 
meter equipped with the polarizing accessories. 
2.1. Polarization 
Polarization, P, of a molecule is expressed quan- 
titatively in terms of intensities, I, polarized either 
parallel (II) or perpendicular (I ) to the incident 
electric field and can be calculated according to the 
equation: 
III + 11 390 420 450 480 390 420 450 480 
2.2. Scatchard analysis 
r = mol of drug bound per mol of tubulin 
= (F,/F,)/(P,/G,), where 
Fc = the fluorescence of a given solution of 
drug-tubulin complex; 
F, = the fluorescence of an equal concentration 
of drug in excess tubulin, such that all 
the drug is bound; 
WAVE LENGTH (nm) 
Fig.2. Fluorescence mission spectra of the drug-tubulin 
complex. Mixture of 14.5 pM tubulin and 10 ,uM drug in 
buffer A was incubated at 37°C for 30 min. The excita- 
tion wavelength was 350 nm. Panel A, desacetamidocol- 
chicine: 1, free drug; 2, drug-tubulin complex; Panel B, 
2-methoxy-S-(2’,3’,4’-trimethoxyphenyl) tropone: 1, 
free drug; 2, drug-tub&n complex. 
C, = the total drug concentration; 
P,, = is the total protein concentration. 
From the known total concentration of drug and 
tubulin and the measured value of r, the free col- 
chicine concentration, C, is calculated from the 
relation C = C, - rPO. 
All binding experiments were carried out in buf- 
fer A of pH 6.4 with the following composition: 
25 mM 2-(N-morpholino) ethane sulfonic acid 
(MES), 1 mM 2-mercaptoethanol, 0.5 mM Mg2+, 
0.1 mM GTP. Phosphocellulose (Pll) was ob- 
tained from Whatmann. MES and GTP were from 
Sigma and other chemicals were of analytical 
grades. 
3. RESULTS 
It has been reported earlier that colchicine has 
no intrinsic fluorescence, however, induction of 
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fluorescence occurs when the drug binds to tubulin 
[9]. Compared to colchicine its two structural ana- 
logues desacetamidocolchicine and 2-methoxy-5- 
(2’,3’,4’-trimethoxyphenyl) tropone have slight 
fluorescence in buffer A which enhanced in the 
presence of tubulin. The fluorescence emission 
spectra of desacetamidocolchicine and 2-methoxy- 
5-(2’,3’,4’-trimethoxyphenyl) tropone are shown 
(fig.2). Like colchicine, both analogues have emis- 
sion maxima at 430 nm when combined with tubu- 
lin. In the free state both drugs have emission 
maxima at around 405 nm and increase in the 
hydrophobic character of the solvents (using dif- 
ferent organic solvents) do not lead to any en- 
han_cement in fluorescence. 
Polarization of a molecule depends on its size, 
molecular geometry and rigidity. Tropolone moiety 
(ring-C) responsible for the colchicine fluorescence 
is highly rigid in desacetamidocolchicine whereas it 
can assume an infinity of conformations by free 
rotations around the single bond between A and C- 
ring in the case of 2-methoxy-5-(2’,3’,4’-trimeth- 
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Fig.3. Titration of desacetamidocolchicine and 2- meth- 
oxy-5-(2’,3’,4’-trimethoxyphenyl) tropone with purified 
tubulin in buffer A. Aliquots of tubulin were incubated 
with 5 x lo-’ M drug for 30 min. The polarization was 
measured as described in section 2 for each concentra- 
tion of tubulin. Inset: Double reciprocal plot of the data. 
(A) Desacetamidocolchicine; (B) 2-methoxy-5- 
(2’,3’,4’-trimethoxyphenyl) tropone. 
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Fig.4. Binding parameters of the drug-tubulin complex. 
(A) Desacetamidocolchicine-tubulin fluorescence at 
430 nm (F430) as a function of increasing amounts of 
tubulin in buffer A. 2pM drug, incubated at 37°C for 
30 min. Inset: Scatchard analysis of the data, calculated 
as described in section 2. (B) 2-Methoxy-5-(2’,3’,4’-tri- 
methoxyphenyl) tropone-tubulin fluorescence at 430 nm 
(fi30) as a function of increasing amounts of tubulin in 
buffer A. 5 PM drug, incubated at 37°C for 30 min. 
Inset: Scatchard analysis of the data, calculated as 
described in section 2. 
oxyphenyl) tropone. However, the polarization of 
both drugs are nearly zero in free state. Binding to 
tubulin however accompanied by a significant in- 
crease in the polarization of fluorescence of both 
desacetamidocolchicine and 2-methoxy-5-(2’,3’,4’- 
trimethoxyphenyl) tropone. Increase in the fluores- 
cence polarization of desacetamidocolchicine (5 x 
lo-’ M) and 2-methoxy-5-(2’,3’,4’-trimethoxy- 
phenyl) tropone (5 x lo-’ M) with increase in 
tubulin concentrations are shown (fig.3). From 
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this typical binding equilibrium, the number of 
binding parameters of drug tubulin interactions 
are determined by means of double reciprocal 
plots. Plot of l/polarization vs l/[tubulin] for 
desacetamidocolchicine (inset fig.3A) and 2-meth- 
oxy-5-(2’,3’,4’-trimethoxyphenyl) tropone (inset 
fig.3B) are shown. The intercept of such a plot is 
l/P,,,, and the slope is equal to &/P,,,,, when Kd 
is the dissociation constant for the tubulin-drug 
complex. Thus the dissociation constants calcu- 
lated for desacetamidocolchicine and 2-methoxy-5 
(2’,3’,4’-trimethoxyphenyl) tropone are 1.25 x 
10m6 M and 1.08 x low6 M, respectively. 
The tubulin-induced fluorescence of desacetami- 
docolchicine and 2-methoxy-5-(2’,3’,4’-trimethoxy- 
phenyl) tropone were also used to determine the 
affinity constants and the stoichiometries of the 
drug-tubulin complex. The number of binding 
sites were determined from the fluorescence titra- 
tion curves (fig.4), from a plot of r/C against r 
(fig.4, insets). The affinity constants are 1.6 x 
lo6 M-’ for desacetamidocolchicine and 0.58 x 
lo6 M-’ for 2-methoxy-5-(2’,3’,4’-trimethoxy- 
phenyl) tropone. Stoichiometries are 0.8 for 
desacetamidocolchicine and 0.9 for 2-methoxy-5- 
(2’,3’,4’-trimethoxyphenyl) tropone. Thus the 
values of binding parameters determined by two 
different methods are comparable. 
4. DISCUSSION 
Importance of B-ring of colchicine in its binding 
to tubulin is emphasized recently from this labora- 
tory. It was reported that two important unusual 
properties of colchicine-tubulin interaction such as 
slow association rate (which needs long incubation 
time at 37°C) and the high temperature coefficient 
are phenomena of the B-ring substituents of col- 
chicine [7]. Thus, colchicine analogues with smal- 
ler (colcemid) or no substituents in the B-ring 
(desacetamidocolchicine) bind tubulin remarkably 
faster than the colchicine [7,8]. A compound with- 
out the B-ring (2-methoxy-5-[2’,3’,4’-trimethoxy- 
phenyl] tropone) binds tubulin at 4°C and the 
binding is almost instantaneous at 37°C. Although 
it is known that these two important structural 
analogues of colchicine bind to tubulin at the same 
site where colchicine binds and inhibits in vivo and 
in vitro polymerization of tubulin [7,14], this 
paper documents for the first time the important 
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binding parameters uch as affinity constant and 
stoichiometry of those drugs with tubulin. 
Due to their small size the low molecular mass 
compounds will give rise to a depolarized fluores- 
cence and therefore, an increase in the polarization 
of colchicine analogues binding to tubulin was 
anticipated. Very similar polarization values of 
both desacetamidocolchicine and 2-methoxy-5- 
(2’,3’,4’-trimethoxyphenyl) tropone in the presence 
of tubulin indicate that the tropolone moiety in 
both compounds are equally rigid in spite of the 
absence of B-ring in the latter. Appreciable changes 
in the fluorescence polarization of desacetamido- 
colchicine and 2-methoxy-5-(2’,3’,4’-trimethoxy- 
phenyl) tropone as a consequence of their binding 
to tubulin have been utilized for measuring the 
binding parameters of their interaction. 
Since the fluorescence of desacetamidocolchi- 
tine and 2-methoxy-5-(2’,3’,4’-trimethoxyphenyl) 
tropone enhanced significantly in the presence of 
tubulin, this also provides an opportunity to com- 
pare the binding parameters obtained by fluores- 
cence enhancement. The affinity constants deter- 
mined by fluorescence polarization is in agreement 
with the values determined by fluorescence en- 
hancement. 
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